Berenberg Bank Maintains Fresenius Medical Care(FMS.US) With Buy Rating, Maintains Target Price $28.9
Truist Financial Maintains Fresenius Medical Care(FMS.US) With Hold Rating
Analysts Conflicted on These Healthcare Names: Spyre Therapeutics (SYRE), Fresenius Medical Care (FMS) and Jazz Pharmaceuticals (JAZZ)
Goldman Sachs Sticks to Their Buy Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Berenberg Bank Keeps Their Buy Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Research Alert: CFRA Keeps Sell Opinion On Adss Of Fresenius Medical Care
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Hold From UBS
Deutsche Bank Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
J.P. Morgan Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Research Alert: Treatment Growth Hit By Severe Flu Season, But Q1 2025 Beats Estimates
Jefferies Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Analysts Offer Insights on Healthcare Companies: Fresenius Medical Care (FMS), Merck & Company (MRK) and Insmed (INSM)
Bernstein Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)
Erste Group Initiates Fresenius Medical Care(FMS.US) With Buy Rating
Bernstein Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
BofA Securities Maintains Fresenius Medical Care(FMS.US) With Hold Rating
Truist Financial Maintains Fresenius Medical Care(FMS.US) With Hold Rating
Deutsche Bank Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)
UBS Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Bernstein Maintains Fresenius Medical Care(FMS.US) With Hold Rating, Maintains Target Price $26